v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 0 $ 0 $ 0 $ 0
Operating Expenses        
General and administrative 1,515,899 2,028,667 3,298,759 3,965,421
Research and development 273,314 115,776 642,764 505,600
Total Operating Expenses 1,789,213 2,144,443 3,941,523 4,471,021
Other Operating Income        
Distribution from joint venture 110,000 0 110,000 0
Grant income 67,794 0 171,113 0
Total Other Operating Income 177,794 0 281,113 0
Operating Loss (1,611,419) (2,144,443) (3,660,410) (4,471,021)
Other Income        
Interest income 1,322 12,337 4,631 74,829
Foreign currency transaction gain 0 0 33,694 0
Total Other Income 1,322 12,337 38,325 74,829
Net Loss Before Income Taxes (1,610,097) (2,132,106) (3,622,085) (4,396,192)
Income taxes 0 0 0 0
Net Loss (1,610,097) (2,132,106) (3,622,085) (4,396,192)
Accumulated preferred stock dividend (133,313) (128,238) (264,747) (254,149)
Deemed additional dividend on preferred stock dividend due to the beneficial conversion feature (58,408) (55,294) (115,897) (109,611)
Net loss attributable to common stockholders $ (1,801,818) $ (2,315,638) $ (4,002,729) $ (4,759,952)
Net Loss Per Common Share, Basic and Diluted $ (0.27) $ (0.66) $ (0.61) $ (1.40)
Weighted Average Number of Common Shares Outstanding 6,595,483 3,486,566 6,592,454 3,390,782

Source